-
Notifications
You must be signed in to change notification settings - Fork 0
How to cite: Van De Vyver, A.J., Eigenmann, M.J., Ovacik, M., Pöhl, C., Herter, S., Weinzierl, T., Fauti, T., Klein, C., Lehr, T., Bacac, M., Walz, A.-C. (2021). A novel approach for quantifying the pharmacological activity of T cell engagers utilizing in vitro time course experiments and streamlined data analysis. AAPS
PKPD-coder/time-independent_analysis_in_vitro
Folders and files
Name | Name | Last commit message | Last commit date | |
---|---|---|---|---|
Repository files navigation
Read-me This repository serves as an addendum to the following peer-reviewed article pulished in the AAPS journal (2021): --------------------------------------------------------------------------------------------------------------------------- A novel approach for quantifying the pharmacological activity of T-cell engagers utilizing in vitro time-course experiments and streamlined data analysis Arthur J Van De Vyver, Miro Eigenmann, Meric Ovacik, Christian Pohl, Sylvia Herter, Tina Weinzierl, Tanja Fauti, Christian Klein, Thorsten Lehr, Marina Bacac, Antje-Christine Walz --------------------------------------------------------------------------------------------------------------------------- This repository contains two Python files that serve as tools to explore the pharmacology of CD3-bispecific antibodies 1) time-independent PKPD analysis - AAPS.py This file allows the reader to upload their own experimental dataset and perform a time-independent analysis. The dataset needs to be prepared in Excel (.xlsx) format and contain the following information in separate columns: a) measured time points (column name 'Time') b) tested drug concentrations (column name 'Conc') c) tested compounds (column name 'Drug') d) tested cell lines (column name 'CellLine') e) readouts of interest (column name 'Readout') f) observed data (column name 'Obs') The path to the data file can be specified on line 231 It is encouraged to explicitly name the experimental conditions and compounds in the dataset as to allow easier navigation through and in the output files Please provide an empty folder ('Figures') to store the output figures The outputs of the time-independent analysis include: a) plots of raw data per experimental conditions (denoted by the readout and experimental condition) b) EC50 estimations at different time points (denoted ‘Potency Change Over Time’) c) EC50 estimation across different experimental conditions including different cells lines and different drugs (denoted ‘Cumulative Potency’) d) sigmoidal model fits for each experimental condition (denoted ‘Model Fit’) e) estimated sigmoidal model parameters for the model fits including RSE% values ('Sigmoidal Model Parameters.txt') f) simulations for sigmoidal fits for each experimental condition ('Sigmoidal Model Simulations.xls') g) calculated AUCE values (AUCE.xls) as well as Hockey-Stick model fits (denoted with 'HOCKEYSTICK') h) estimated model parameters including RSE% values ('Hockey Stick Parameters.txt') i) simulations for Hockey stick fits for each experimental condition ('Hockey Stick Model Simulations.xls') 2) QE_synapse_calculation.py Based on the equations derived by Schropp and colleagues (1) to calculate the number of immune synapses (i.e., trimeric complexes) between CD3-bispecific antibodies, tumor cells, and T-cells under quasi-equilibrium (QE) assumptions. The equations are summarised in 'QE equations summary.pdf' The code enables the calculation of the concentration of immune synapses formed under the experimental conditions specified by the user. If desired, a plot can be generated showing immune synapse formation over a range of concentrations and visualise the bell-shape. Please provide an empty folder ('Figures') to store the output figure. An additional plot can be generated to compare the simulations under QE assumptions with those of the full ODE model References: (1) Schropp J, Khot A, Shah DK, Koch G. Target-Mediated Drug Disposition Model for Bispecific Antibodies: Properties, Approximation, and Optimal Dosing Strategy. CPT: Pharmacometrics & Systems Pharmacology. 2019;8(3):177-87. doi: 10.1002/psp4.12369.
About
How to cite: Van De Vyver, A.J., Eigenmann, M.J., Ovacik, M., Pöhl, C., Herter, S., Weinzierl, T., Fauti, T., Klein, C., Lehr, T., Bacac, M., Walz, A.-C. (2021). A novel approach for quantifying the pharmacological activity of T cell engagers utilizing in vitro time course experiments and streamlined data analysis. AAPS
Topics
Resources
Stars
Watchers
Forks
Releases
No releases published
Packages 0
No packages published